Ajanta Pharma advances despite reporting 7% fall in Q2 consolidated net profit

06 Nov 2019 Evaluate

Ajanta Pharma is currently trading at Rs. 1013.85, up by 11.45 points or 1.14% from its previous closing of Rs. 1002.40 on the BSE.

The scrip opened at Rs. 1025.00 and has touched a high and low of Rs. 1033.00 and Rs. 996.15 respectively. So far 16048 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1204.25 on 31-Dec-2018 and a 52 week low of Rs. 840.00 on 31-Jul-2019.

Last one week high and low of the scrip stood at Rs. 1088.00 and Rs. 906.50 respectively. The current market cap of the company is Rs. 8825.60 crore.

The promoters holding in the company stood at 70.51%, while Institutions and Non-Institutions held 20.14% and 9.35% respectively.

Ajanta Pharma has reported a rise of 15.95% in its net profit at Rs 120.70 crore for the quarter ended September 30, 2019 as compared to Rs 104.10 crore for the same quarter in the previous year. Total income of the company increased by 24.17% at Rs 598.76 crore for Q2FY20 as compared Rs 482.22 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 7.20% in its net profit at Rs 116.36 crore for the quarter under review as compared to Rs 125.39 crore for the same quarter in the previous year. However, total income of the company increased by 17.28% at Rs 655.98 crore for Q2FY20 as compared Rs 559.35 crore for the corresponding quarter previous year.

Ajanta Pharma Share Price

2060.75 -44.75 (-2.13%)
16-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1536.95
Dr. Reddys Lab 6038.00
Cipla 1384.30
Zydus Lifesciences 937.80
Lupin 1613.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.